8legs: European society for radiotherapy and oncology

#1 out of 10.00%

Doctors may have found an easier way to treat prostate cancer — could become new ‘standard of care’

ESTRO 2026 study finds two-session radiotherapy for prostate cancer is as effective as five-dose regimens.
Two-dose approach showed similar side effects to the traditional regimen over a two-year follow-up.
The two-session therapy could reduce hospital visits and lower treatment costs.
The study used an MRI-guided machine to precisely target the prostate and spare healthy tissue.
The research indicates the new approach could become a new standard of care with broader access as centers acquire the technology.
Two-dose treatment may benefit patients with limited mobility or distance from centers.
Urinary side effects occurred in about one in four patients across both regimens.
No severe urinary or bowel complications were reported in either treatment group after two years.
The study involved 46 prostate cancer patients divided into two dosing schedules.
Researchers used MRI-guided radiotherapy to balance efficacy with preservation of healthy tissue.

Vote 0